Drugs / POTASSIUM PHOSPHATE, UNSPECIFIED FORM

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) AMINOSYN 10% (PH6) 1975-12-03 fda.gov

Trials 3 · a red edge is where a trial was stopped

19751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT07681050 Jul 2026 → Jul 2028 expected acute pancreatitis Duke University Recruiting No outcome recorded
Phase 31 trial
Phase 3 NCT00004284 Apr 1995 → ? idiopathic hypercalciuria, nephrolithiasis National Center for Research Resources (NCRR) Completed No outcome recorded
Phase 41 trial
Phase 4 NCT04026438 Jan 2019 → Feb 2021 post-surgical hypoinsulinemia Institute of Liver and Biliary Sciences, India Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT02866435 Background Nov 2016 → Sep 2019 hypoglycemia University of Minnesota Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as POTASSIUM PHOSPHATE, UNSPECIFIED FORM ChEMBL registry synonym — accepted as the source's own label CHEMBL4298074
Known as Kali phosphoricum ChEMBL registry synonym — accepted as the source's own label CHEMBL4298074
Known as Kalium phosphoricum ChEMBL registry synonym — accepted as the source's own label CHEMBL4298074
Known as Potassium (as phosphate) ChEMBL registry synonym — accepted as the source's own label CHEMBL4298074
Known as Potassium Phosphate ClinicalTrials.gov intervention name — accepted as the source's own label NCT07681050
3

NCT02866435

NCT04026438

NCT00004284

Route Oral “Patients receive potassium phosphate or potassium citrate tablets twice a day for 3 years.” NCT00004284